1
|
Zebrowska A, Jelonek K, Mondal S, Gawin M, Mrowiec K, Widłak P, Whiteside T, Pietrowska M. Proteomic and Metabolomic Profiles of T Cell-Derived Exosomes Isolated from Human Plasma. Cells 2022; 11:1965. [PMID: 35741093 PMCID: PMC9222142 DOI: 10.3390/cells11121965] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 06/13/2022] [Accepted: 06/17/2022] [Indexed: 02/04/2023] Open
Abstract
Exosomes that are released by T cells are key messengers involved in immune regulation. However, the molecular profiling of these vesicles, which is necessary for understanding their functions, requires their isolation from a very heterogeneous mixture of extracellular vesicles that are present in the human plasma. It has been shown that exosomes that are produced by T cells could be isolated from plasma by immune capture using antibodies that target the CD3 antigen, which is a key component of the TCR complex that is present in all T lymphocytes. Here, we demonstrate that CD3(+) exosomes that are isolated from plasma can be used for high-throughput molecular profiling using proteomics and metabolomics tools. This profiling allowed for the identification of proteins and metabolites that differentiated the CD3(+) from the CD3(-) exosome fractions that were present in the plasma of healthy donors. Importantly, the proteins and metabolites that accumulated in the CD3(+) vesicles reflected the known molecular features of T lymphocytes. Hence, CD3(+) exosomes that are isolated from human plasma by immune capture could serve as a "T cell biopsy".
Collapse
Affiliation(s)
- Aneta Zebrowska
- Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland; (A.Z.); (K.J.); (M.G.); (K.M.)
| | - Karol Jelonek
- Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland; (A.Z.); (K.J.); (M.G.); (K.M.)
| | - Sujan Mondal
- UPMC Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA;
| | - Marta Gawin
- Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland; (A.Z.); (K.J.); (M.G.); (K.M.)
| | - Katarzyna Mrowiec
- Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland; (A.Z.); (K.J.); (M.G.); (K.M.)
| | - Piotr Widłak
- Clinical Research Support Centre, Medical University of Gdańsk, 80-210 Gdańsk, Poland
| | - Theresa Whiteside
- UPMC Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA;
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
- Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
| | - Monika Pietrowska
- Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland; (A.Z.); (K.J.); (M.G.); (K.M.)
| |
Collapse
|
2
|
Pietrowska M, Zebrowska A, Gawin M, Marczak L, Sharma P, Mondal S, Mika J, Polańska J, Ferrone S, Kirkwood JM, Widlak P, Whiteside TL. Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progression. J Extracell Vesicles 2021; 10:e12063. [PMID: 33613873 PMCID: PMC7876545 DOI: 10.1002/jev2.12063] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Revised: 12/07/2020] [Accepted: 01/12/2021] [Indexed: 02/04/2023] Open
Abstract
Molecular profiling of small extracellular vesicles (sEV) isolated from plasma of cancer patients emerges as promising strategy for biomarkers discovery. We investigated the proteomic profiles of sEV immunoselected using anti-CSPG4 antibodies from 15 melanoma patients' plasma. The proteomes of sEV separated into melanoma cell-derived (MTEX) and non-malignant cell-derived (NMTEX) were compared using high-resolution mass spectrometry. Paired analysis identified the MTEX-associated profile of 16 proteins that discriminated MTEX from NMETEX. We also identified the MTEX profile that discriminated between seven patients with no evidence of melanoma (NED) after therapy and eight with progressive disease (PD). Among 75 MTEX proteins overexpressed in PD patients, PDCD6IP (ALIX) had the highest discriminating value, while CNTN1 (contactin-1) was upregulated only in MTEX of NED patients. This is the first report documenting that proteomes of tumour-derived sEV in patients' plasma discriminate cancer from non-cancer and identify proteins with potential to serve as prognostic biomarkers in melanoma.
Collapse
Affiliation(s)
- Monika Pietrowska
- Maria Sklodowska‐Curie National Research Institute of OncologyGliwicePoland
| | - Aneta Zebrowska
- Maria Sklodowska‐Curie National Research Institute of OncologyGliwicePoland
| | - Marta Gawin
- Maria Sklodowska‐Curie National Research Institute of OncologyGliwicePoland
| | - Lukasz Marczak
- European Center for Bioinformatics and GenomicsInstitute of Bioorganic Chemistry PASPoznanPoland
| | - Priyanka Sharma
- UPMC Hillman Cancer CenterUniversity of Pittsburgh Cancer InstitutePittsburghPennsylvaniaUSA
| | - Sujan Mondal
- UPMC Hillman Cancer CenterUniversity of Pittsburgh Cancer InstitutePittsburghPennsylvaniaUSA
| | - Justyna Mika
- Department of Data Science and Engineering, Silesian University of TechnologyGliwicePoland
| | - Joanna Polańska
- Department of Data Science and Engineering, Silesian University of TechnologyGliwicePoland
| | - Soldano Ferrone
- Department of SurgeryHarvard Medical School, Massachusetts General HospitalBostonMassachusettsUSA
| | - John M. Kirkwood
- UPMC Hillman Cancer CenterUniversity of Pittsburgh Cancer InstitutePittsburghPennsylvaniaUSA,Department of MedicineUniversity of Pittsburgh School of MedicinePittsburghPennsylvaniaUSA
| | - Piotr Widlak
- Maria Sklodowska‐Curie National Research Institute of OncologyGliwicePoland
| | - Theresa L. Whiteside
- UPMC Hillman Cancer CenterUniversity of Pittsburgh Cancer InstitutePittsburghPennsylvaniaUSA,Department of PathologyUniversity of Pittsburgh School of MedicinePittsburghPennsylvaniaUSA
| |
Collapse
|
3
|
Masmoudi W, Vaillant M, Vassileva S, Patsatsi A, Quereux G, Moltrasio C, Abasq C, Prost-Squarcioni C, Kottler D, Kiritsi D, Litrowski N, Plantin P, Friedrichsen L, Zebrowska A, Duvert-Lehembre S, Hofmann S, Ferranti V, Jouen F, Joly P, Hebert V. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid. Br J Dermatol 2020; 184:1106-1112. [PMID: 33067805 DOI: 10.1111/bjd.19611] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/15/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND The Bullous Pemphigoid Disease Area Index (BPDAI) score has been proposed to provide an objective measure of bullous pemphigoid (BP) activity. OBJECTIVES The objective of this study was to calculate BPDAI cut-off values defining mild, moderate and severe BP. We also aimed to assess the interrater reliability and correlation with the number of daily new blisters, and anti-BP180 and anti-BP230 antibodies. METHODS Severity scores were recorded by two blinded investigators. Anti-BP180 and anti-BP230 antibodies were measured using an enzyme-linked immunosorbent assay (ELISA). Cut-off values defining mild, moderate and severe subgroups were calculated based on the 25th and 75th percentiles of the BPDAI score. RESULTS In total, 285 patients with BP were enrolled from 50 dermatology departments in Europe. Median BPDAI activity was 37·5 points (range 0-164). Cut-off values corresponding to the first and third quartiles of the BPDAI score were 20 and 57, respectively; thus, these values were used to define mild (≤ 19), moderate (≥ 20 and ≤ 56) and severe (≥ 57) BP. The median BPDAI score for patients with ≤ 10 daily new blisters was 26 [interquartile range (IQR) 17-45], and for patients with > 10 daily new blisters the median score was 55 (IQR 39-82). The BPDAI intraclass correlation coefficient measured at baseline was 0·97 and remained higher than 0·90 up to month 6. The improvement in the BPDAI score was correlated with the absolute decrease in anti-BP180 ELISA value (Spearman's rank r = 0·34, P < 0·004), but not with anti-BP230 antibodies (r = 0·17, P = 0·15). CONCLUSIONS This study suggests cut-off values of 20-57 for BPDAI to distinguish mild, moderate and severe BP, and confirms that it is a robust tool to assess BP severity precisely.
Collapse
Affiliation(s)
- W Masmoudi
- Department of Dermatology, Centre de Référence des Maladies Bulleuses Autoimmunes
| | - M Vaillant
- Department of Immunology, INSERM U1234, Rouen University Hospital, Rouen, France
| | - S Vassileva
- Department of Dermatology, Medical University of Sofia, Sofia, Bulgaria
| | - A Patsatsi
- 2nd Department of Dermatology and Venerology, Papageorgiou General Hospital, Aristotle University School of Medicine, Thessaloniki, Greece
| | - G Quereux
- Department of Dermatology, Nantes University Hospital, Nantes, France
| | - C Moltrasio
- Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - C Abasq
- Department of Dermatology, Brest University Hospital, Brest, France
| | - C Prost-Squarcioni
- Department of Dermatology, Avicenne Hospital, University Paris 13, Bobigny, France
| | - D Kottler
- Department of Dermatology, Bichat Hospital, AP-HP, Paris, France
| | - D Kiritsi
- Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany
| | - N Litrowski
- Department of Dermatology, Monod General Hospital, Le Havre, France
| | - P Plantin
- Department of Dermatology, Centre Hospitalier de Cornouaille, Quimper, France
| | - L Friedrichsen
- Department of Dermatology, University of Lubeck, Lubeck, Germany
| | - A Zebrowska
- Department of Dermatology and Venerology, Medical University of Lodz, Lodz, Poland
| | | | - S Hofmann
- Department of Dermatology, HELIOS University of Wuppertal, Wuppertal, Germany
| | - V Ferranti
- Department of Dermatology, Centre de Référence des Maladies Bulleuses Autoimmunes
| | - F Jouen
- Department of Dermatology, Centre de Référence des Maladies Bulleuses Autoimmunes.,Department of Immunology, INSERM U1234, Rouen University Hospital, Rouen, France
| | - P Joly
- Department of Dermatology, Centre de Référence des Maladies Bulleuses Autoimmunes.,Department of Immunology, INSERM U1234, Rouen University Hospital, Rouen, France
| | - V Hebert
- Department of Dermatology, Centre de Référence des Maladies Bulleuses Autoimmunes.,Department of Immunology, INSERM U1234, Rouen University Hospital, Rouen, France
| | | |
Collapse
|
4
|
Wojakowska A, Zebrowska A, Skowronek A, Rutkowski T, Polanski K, Widlak P, Marczak L, Pietrowska M. Metabolic Profiles of Whole Serum and Serum-Derived Exosomes Are Different in Head and Neck Cancer Patients Treated by Radiotherapy. J Pers Med 2020; 10:jpm10040229. [PMID: 33203021 PMCID: PMC7711528 DOI: 10.3390/jpm10040229] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 11/09/2020] [Accepted: 11/13/2020] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND In general, the serum metabolome reflects the patient's body response to both disease state and implemented treatment. Though serum-derived exosomes are an emerging type of liquid biopsy, the metabolite content of these vesicles remains under researched. The aim of this pilot study was to compare the metabolite profiles of the whole serum and serum-derived exosomes in the context of differences between cancer patients and healthy controls as well as patients' response to radiotherapy (RT). METHODS Serum samples were collected from 10 healthy volunteers and 10 patients with head and neck cancer before and after RT. Metabolites extracted from serum and exosomes were analyzed by the gas chromatography-mass spectrometry (GC-MS). RESULTS An untargeted GC-MS-based approach identified 182 and 46 metabolites in serum and exosomes, respectively. Metabolites that differentiated cancer and control samples, either serum or exosomes, were associated with energy metabolism. Serum metabolites affected by RT were associated with the metabolism of amino acids, sugars, lipids, and nucleotides. CONCLUSIONS cancer-related features of energy metabolism could be detected in both types of specimens. On the other hand, in contrast to RT-induced changes observed in serum metabolome, this pilot study did not reveal a specific radiation-related pattern of exosome metabolites.
Collapse
Affiliation(s)
- Anna Wojakowska
- Institute of Bioorganic Chemistry Polish Academy of Sciences, 61-704 Poznan, Poland;
| | - Aneta Zebrowska
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; (A.Z.); (A.S.); (T.R.); (P.W.)
| | - Agata Skowronek
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; (A.Z.); (A.S.); (T.R.); (P.W.)
| | - Tomasz Rutkowski
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; (A.Z.); (A.S.); (T.R.); (P.W.)
| | - Krzysztof Polanski
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK;
| | - Piotr Widlak
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; (A.Z.); (A.S.); (T.R.); (P.W.)
| | - Lukasz Marczak
- Institute of Bioorganic Chemistry Polish Academy of Sciences, 61-704 Poznan, Poland;
- Correspondence: (L.M.); (M.P.)
| | - Monika Pietrowska
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; (A.Z.); (A.S.); (T.R.); (P.W.)
- Correspondence: (L.M.); (M.P.)
| |
Collapse
|
5
|
Zebrowska A, Widlak P, Whiteside T, Pietrowska M. Signaling of Tumor-Derived sEV Impacts Melanoma Progression. Int J Mol Sci 2020; 21:ijms21145066. [PMID: 32709086 PMCID: PMC7404104 DOI: 10.3390/ijms21145066] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Revised: 07/14/2020] [Accepted: 07/15/2020] [Indexed: 12/12/2022] Open
Abstract
Small extracellular vesicles (sEV or exosomes) are nanovesicles (30–150 nm) released both in vivo and in vitro by most cell types. Tumor cells produce sEV called TEX and disperse them throughout all body fluids. TEX contain a cargo of proteins, lipids, and RNA that is similar but not identical to that of the “parent” producer cell (i.e., the cargo of exosomes released by melanoma cells is similar but not identical to exosomes released by melanocytes), possibly due to selective endosomal packaging. TEX and their role in cancer biology have been intensively investigated largely due to the possibility that TEX might serve as key component of a “liquid tumor biopsy.” TEX are also involved in the crosstalk between cancer and immune cells and play a key role in the suppression of anti-tumor immune responses, thus contributing to the tumor progression. Most of the available information about the TEX molecular composition and functions has been gained using sEV isolated from supernatants of cancer cell lines. However, newer data linking plasma levels of TEX with cancer progression have focused attention on TEX in the patients’ peripheral circulation as potential biomarkers of cancer diagnosis, development, activity, and response to therapy. Here, we consider the molecular cargo and functions of TEX as potential biomarkers of one of the most fatal malignancies—melanoma. Studies of TEX in plasma of patients with melanoma offer the possibility of an in-depth understanding of the melanoma biology and response to immune therapies. This review features melanoma cell-derived exosomes (MTEX) with special emphasis on exosome-mediated signaling between melanoma cells and the host immune system.
Collapse
Affiliation(s)
- Aneta Zebrowska
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-100 Gliwice, Poland; (A.Z.); (P.W.)
| | - Piotr Widlak
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-100 Gliwice, Poland; (A.Z.); (P.W.)
| | - Theresa Whiteside
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA;
- Department of Pathology, University of Pittsburgh School of Medicine Pittsburgh, Pittsburgh, PA 15261, USA
| | - Monika Pietrowska
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-100 Gliwice, Poland; (A.Z.); (P.W.)
- Correspondence: ; Tel.: +48-32-278-9627
| |
Collapse
|
6
|
Bastos S, Hebert V, Vassileva S, Patsatsi A, Meijer J, Quéreux G, Bedane C, Prost-Squarcioni C, Debardieux S, Oro S, Chaby G, D’Incan M, Litrowski N, Boulard C, Lunardon L, Kiritsi D, Jedlickova H, Feliciani C, Roussel A, Kottler D, Plantin P, Richard MA, Friedrichsen L, Abasq C, Duvert Lehembre S, Gottlieb J, Zebrowska A, Hofmann S, Joly P. Efficacité et tolérance de la prednisone à 0,5 mg/kg/j en traitement initial de la pemphigoïde bulleuse. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
7
|
Zebrowska A, Skowronek A, Wojakowska A, Widlak P, Pietrowska M. Metabolome of Exosomes: Focus on Vesicles Released by Cancer Cells and Present in Human Body Fluids. Int J Mol Sci 2019; 20:ijms20143461. [PMID: 31337156 PMCID: PMC6678201 DOI: 10.3390/ijms20143461] [Citation(s) in RCA: 59] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Revised: 07/10/2019] [Accepted: 07/11/2019] [Indexed: 02/07/2023] Open
Abstract
Exosomes and other classes of extracellular vesicles (EVs) have gained interest due to their role in cell-to-cell communication. Knowledge of the molecular content of EVs may provide important information on features of parental cells and mechanisms of cross-talk between cells. To study functions of EVs it is essential to know their composition, that includes proteins, nucleic acids, and other classes biomolecules. The metabolome, set of molecules the most directly related to the cell phenotype, is the least researched component of EVs. However, the metabolome of EVs circulating in human blood and other bio-fluids is of particular interest because of its potential diagnostic value in cancer and other health conditions. On the other hand, the metabolome of EVs released to culture media in controlled conditions in vitro could shed light on important aspects of communication between cells in model systems. This paper summarizes the most common approaches implemented in EV metabolomics and integrates currently available data on the composition of the metabolome of EVs obtained in different models with particular focus on human body fluids and cancer cells.
Collapse
Affiliation(s)
- Aneta Zebrowska
- Maria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, 44-100 Gliwice, Poland
| | - Agata Skowronek
- Maria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, 44-100 Gliwice, Poland
| | - Anna Wojakowska
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, 44-100 Poznan, Poland
| | - Piotr Widlak
- Maria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, 44-100 Gliwice, Poland
| | - Monika Pietrowska
- Maria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, 44-100 Gliwice, Poland.
| |
Collapse
|
8
|
Kostorz S, Jastrzębski D, Sikora M, Zebrowska A, Margas A, Stepanik D, Swinder H, Ziora D. Predominance of Comorbidities in the Detriment of Daily Activity in Sarcoidosis Patients. Adv Exp Med Biol 2018; 1040:7-12. [PMID: 28804812 DOI: 10.1007/5584_2017_87] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/07/2023]
Abstract
Sarcoidosis may affect lung function, working ability, overall mobility, and daily activity. In the present study we performed an analysis of clinical settings in patients with sarcoidosis to disentangle its influence on daily physical activity (PA). PA assessment (number of steps per day, daily energy expenditure) was performed by accelerometry during consecutive 7 days after discharge from hospital. Thirty patients with sarcoidosis, aged 46.4 ± 10.5, were enrolled in the study. Clinical data (age, gender, steroid consumption, weight, and comorbidities), lung function tests (forced expiratory volume in one second - FEV1, forced vital capacity - FVC, and lung diffusion for carbon monoxide - DLCO), mobility (6-minute walk test - 6 MWT) and physical performance (oxygen consumption at anaerobic threshold - VO2/AT) were estimated. The mean daily PA (5214 ± 2699 steps/day) and VO2max (22.3 ± 7.0 ml/kg/min) were lower when referenced to the age-group predicted values. A significant greater daily PA was observed in sarcoidosis patients without comorbidities compared with those having more than two comorbidities (p = 0.046). No association was found between steroid use, lung function, and 6MWT. Daily PA was associated with patients aerobic efficacy and VO2max (r = 0.38, p < 0.04). The findings demonstrate a significant influence of comorbidities on sarcoidosis patients' exercise tolerance and daily PA. Special treatment considerations, including the potential impact of comorbidities, may help optimize exercise regimes, link physical activity with health, and prevent sarcoidosis complications.
Collapse
Affiliation(s)
- S Kostorz
- School of Medicine with the Division of Dentistry, Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 1 Koziołka Street, 41-803, Zabrze, Poland
| | - D Jastrzębski
- School of Medicine with the Division of Dentistry, Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 1 Koziołka Street, 41-803, Zabrze, Poland.
| | - M Sikora
- Department of Physiological and Medical Sciences, The Jerzy Kukuczka Academy of Physical Education, 72A Mikolowska Street, 40-065, Katowice, Poland
| | - A Zebrowska
- Department of Physiological and Medical Sciences, The Jerzy Kukuczka Academy of Physical Education, 72A Mikolowska Street, 40-065, Katowice, Poland
| | - A Margas
- School of Medicine with the Division of Dentistry, Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 1 Koziołka Street, 41-803, Zabrze, Poland
| | - D Stepanik
- School of Medicine with the Division of Dentistry, Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 1 Koziołka Street, 41-803, Zabrze, Poland
| | - H Swinder
- School of Medicine with the Division of Dentistry, Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 1 Koziołka Street, 41-803, Zabrze, Poland
| | - D Ziora
- School of Medicine with the Division of Dentistry, Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 1 Koziołka Street, 41-803, Zabrze, Poland
| |
Collapse
|
9
|
Jastrzebski D, Ochman M, Ziora D, Labus L, Kowalski K, Wyrwol J, Lutogniewska W, Maksymiak M, Ksiazek B, Magner A, Bartoszewicz A, Kubicki P, Hydzik G, Zebrowska A, Kozielski J. Pulmonary Rehabilitation in Patients Referred for Lung Transplantation. Advances in Experimental Medicine and Biology 2013; 755:19-25. [DOI: 10.1007/978-94-007-4546-9_3] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
10
|
Jastrzebski D, Ochman M, Ziora D, Labus L, Kowalski K, Wyrwol J, Lutogniewska W, Maksymiak M, Ksiazek B, Magner A, Bartoszewicz A, Kubicki P, Hydzik G, Zebrowska A, Kozielski J. Pulmonary rehabilitation in patients referred for lung transplantation. Adv Exp Med Biol 2012. [PMID: 22826045 DOI: 10.1007/978-94-007-4545-9_3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Effectiveness of pulmonary rehabilitation in patients with chronic obstructive lung diseases, cystic fibrosis, and interstitial lung disease is well documented but little is known about the results of pulmonary rehabilitation in patients referred for lung transplantation. The purpose of this study is to prospectively examine the efficacy of Nordic walking, a low cost, accessible, and proven beneficial form of physical exercise, as a form of pulmonary rehabilitation in patients referred for lung transplantation. Twenty-two male patients referred for lung transplantation at the Department of Lung Diseases and Tuberculosis in Zabrze, Poland, were invited to take part in the study. The rehabilitation program, which was conducted for 12 weeks, was based on Nordic walking exercise training with ski poles. Lung function tests (FVC, FEV1), mobility (6 min walking test (6MWT)), rating of dyspnea (Oxygen Cost Index, MRC and Baseline Dyspnea Index), and quality of life assessments (SF-36) were performed before and after the completion of the exercise program. No adverse events were observed after completing the pulmonary rehabilitation program in patients referred for lung transplantation. After 12 weeks of pulmonary rehabilitation with Nordic walking we observed a significant increase in the mean distance walked in the 6MWT (310.2 m vs. 372.1 m, p < 0.05). The results of lung function tests also showed improvement in FVC. There were no significant differences in the perception of dyspnea before and after completing the rehabilitation program. General health and quality of life questionnaire (SF-36) showed improvement in the domain of social functioning (p < 0.05). In conclusion, pulmonary rehabilitation with a Nordic walking program is a safe and feasible physical activity in end-stage lung disease patients referred for lung transplantation and results in improvements in patients' mobility and quality of life.
Collapse
Affiliation(s)
- D Jastrzebski
- Department of Lung Diseases and Tuberculosis, Medical University of Silesia, Zabrze, Poland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Zebrowska A, Gawlik K, Zwierzchowska A. Spirometric measurements and physical efficiency in children and adolescents with hearing and visual impairments. J Physiol Pharmacol 2007; 58 Suppl 5:847-857. [PMID: 18204199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
The objective of the study was to investigate whether a sensory impairment has an effect on functional capabilities of the respiratory system and whether possible deviations from reference ranges of selected parameters might indicate a decrease of physical efficiency. Vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), forced expiratory flow of 25-75% (FEF25-75), maximum voluntary volume (MVV), and maximum oxygen uptake VO2 max were measured in 86 deaf and 102 blind children and adolescents, and in a matched group of hearing controls. We found a significant influence of deafness on PEF (P<0.01), FEF25-75 (P<0.05), and MVV (P<0.05). As compared with the control subjects, mean VC was significantly lower in blind adolescents (P<0.05). Our results seem to suggest that both sensory defects during childhood and adolescence affect functional capabilities of the respiratory system.
Collapse
Affiliation(s)
- A Zebrowska
- Department of Physiology, Academy of Physical Education, Katowice, Poland.
| | | | | |
Collapse
|
12
|
Zebrowska A, Zwierzchowska A. Spirometric values and aerobic efficiency of children and adolescents with hearing loss. J Physiol Pharmacol 2006; 57 Suppl 4:443-7. [PMID: 17072075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Vital capacity (VC), forced expiratory volume in 1 s (FEV(1)), peak expiratory flow (PEF), mean forced expiratory flow (FEV(25-75)), and maximum voluntary volume (MVV) were measured in 36 girls and 36 boys with hearing loss and compared with the same number of normal healthy children, all subjects were aged 10-16 years. They participated in an exercise test to calculate VO(2 max) in order to determine their physical efficiency. We found that all spirometric indices tended to be lower in deaf children, in all age-groups studied and irrespective of gender, compared with their hearing counterparts; the differences assumed significance with respect to PEF and MVV (P<0.05). Moreover, some deaf children had an appreciably lower level of VO(2 max) compared with hearing children. Our results demonstrate that sensory deprivation of deaf children affects functional capabilities of the respiratory system.
Collapse
Affiliation(s)
- A Zebrowska
- Department of Physiology, Academy of Physical Education, Katowice, Poland.
| | | |
Collapse
|
13
|
Markiewicz WT, Gröger G, Rösch R, Zebrowska A, Markiewicz M, Klotz M, Hinz M, Godzina P, Seliger H. A new method of synthesis of fluorescently labelled oligonucleotides and their application in DNA sequencing. Nucleic Acids Res 1997; 25:3672-80. [PMID: 9278489 PMCID: PMC146946 DOI: 10.1093/nar/25.18.3672] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
A new approach to the chemical synthesis of oligodeoxynucleotides bearing reporter functional groups at base residues of 3'-end nucleosides is reported. Applications of the 3'-end fluorescently labelled primers for automated DNA sequencing are shown.
Collapse
Affiliation(s)
- W T Markiewicz
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12, PL-61704 Poznan, Poland.
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Seliger H, Hinz M, Klotz M, Wenninger D, Zebrowska A, Markiewicz M, Markiewicz WT. Studies on fluorescent labelling of oligonucleotides. ACTA ACUST UNITED AC 1996. [DOI: 10.1135/cccc1996s301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
15
|
Choussat A, Zebrowska A, Brousson R, Broustet P. [Jervell, Lange-Nielsen syndrome (deaf-mutism and seve heart trouble with syncopal manifestations)]. Rev Laryngol Otol Rhinol (Bord) 1970; 91:546-57. [PMID: 5526578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|